INSERM U 1042, Joseph Fourier University, HP2 Laboratory-Hypoxia: Pathophysiology, La Tronche, France.
J Sleep Res. 2013 Aug;22(4):389-97. doi: 10.1111/jsr.12039. Epub 2013 Feb 15.
Hypoxic brain damage might explain persistent sleepiness in some continuous positive airway pressure-compliant obstructive sleep apnea called residual excessive sleepiness. Although continuous positive airway pressure may not be fully efficient in treating this symptom, wake-promoting drug prescription in residual excessive sleepiness is no longer allowed by the European Medicines Agency. The aim of this study is to describe residual excessive sleepiness phenotypes in a large prospective sample of patients with obstructive sleep apnea. Residual excessive sleepiness was defined by an Epworth Sleepiness Scale score ≥ 11. Eligible patients from the French National Sleep Registry attending follow-up continuous positive airway pressure visits numbered 1047. Patients using continuous positive airway pressure < 3 h (n = 275), with residual apnea-hypopnea index > 15 h⁻¹ (n = 31) or with major depression were excluded (n = 150). Residual excessive sleepiness prevalence in continuous positive airway pressure-treated obstructive sleep apnea was 13% (18% for those with an initial Epworth Sleepiness Scale score > 11), and significantly decreased with continuous positive airway pressure use (9% in ≥ 6 h night⁻¹ continuous positive airway pressure users, P < 0.005). At the time of diagnosis, patients with residual excessive sleepiness had worse subjective appreciation of their disease (general health scale, Epworth Sleepiness Scale and fatigue score), and complained more frequently of continuous positive airway pressure side-effects. Residual excessive sleepiness prevalence was lower in severe obstructive sleep apnea than in moderate obstructive sleep apnea (11% when AHI > 30 h⁻¹ versus 18% when AHI 15-30, P < 0.005). There was no relationship between residual excessive sleepiness and body mass index, cardiovascular co-morbidities or diabetes. Continuous positive airway pressure improved symptoms in the whole population, but to a lower extent in patients with residual excessive sleepiness (fatigue scale: -5.2 versus -2.7 in residual excessive sleepiness- and residual excessive sleepiness+ patients, respectively, P < 0.001). Residual excessive sleepiness prevalence decreased with continuous positive airway pressure compliance. Hypoxic insult is unlikely to explain residual excessive sleepiness as obstructive sleep apnea severity does not seem to be critical. Residual symptoms are not limited to sleepiness, suggesting a true 'continuous positive airway pressure-resistant syndrome', which may justify treatment by wake-promoting drugs.
缺氧性脑损伤可能解释了一些持续气道正压通气治疗有效的阻塞性睡眠呼吸暂停患者中持续嗜睡的原因,这些患者被称为残余过度嗜睡。尽管持续气道正压通气可能无法完全有效治疗这种症状,但欧洲药品管理局已不再允许在残余过度嗜睡患者中开具促醒药物。本研究旨在描述阻塞性睡眠呼吸暂停患者大样本前瞻性研究中残余过度嗜睡的表型。残余过度嗜睡定义为 Epworth 嗜睡量表评分≥11 分。入选法国国家睡眠登记处参加持续气道正压通气随访的患者共 1047 例,排除了使用持续气道正压通气<3 小时(n=275)、残余呼吸暂停低通气指数>15/h(n=31)或有重度抑郁症的患者(n=150)。持续气道正压通气治疗的阻塞性睡眠呼吸暂停患者中残余过度嗜睡的患病率为 13%(初始 Epworth 嗜睡量表评分>11 的患者为 18%),且随着持续气道正压通气的使用而显著下降(夜间持续气道正压通气≥6 小时的患者中为 9%,P<0.005)。在诊断时,残余过度嗜睡的患者对疾病的主观评价较差(一般健康量表、Epworth 嗜睡量表和疲劳评分),并且更频繁地抱怨持续气道正压通气的副作用。在重度阻塞性睡眠呼吸暂停患者中,残余过度嗜睡的患病率低于中度阻塞性睡眠呼吸暂停患者(呼吸暂停低通气指数>30/h 时为 11%,呼吸暂停低通气指数 15-30/h 时为 18%,P<0.005)。残余过度嗜睡与体重指数、心血管合并症或糖尿病无关。持续气道正压通气改善了所有患者的症状,但在残余过度嗜睡患者中的改善程度较低(疲劳量表:残余过度嗜睡和残余过度嗜睡+患者分别为-5.2 和-2.7,P<0.001)。残余过度嗜睡的患病率随持续气道正压通气的依从性而下降。缺氧损伤不太可能解释残余过度嗜睡,因为阻塞性睡眠呼吸暂停的严重程度似乎并不关键。残留症状不仅限于嗜睡,提示存在真正的“持续气道正压通气抵抗综合征”,这可能需要使用促醒药物进行治疗。